Clinical implications of oral candidiasis: Host tissue damage and disseminated bacterial disease

Infection and Immunity

Volumn 83, Issue 2, 2015, Pages 604-613

  Kong, Eric F ^a,b   Kucharíková, Sona ^c   Van Dijck, Patrick ^c   Peters, Brian M ^b,d   Shirtliff, Mark E ^a,b   Jabra Rizka, Mary Ann ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ALS3 PROTEIN, CANDIDA ALBICANS; FUNGAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DYING; FEMALE; FUNGUS HYPHAE; HISTOPATHOLOGY; HOST CELL; LETHARGY; MICROBIAL ADHESION; MIXED INFECTION; MOUSE; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SECONDARY INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYSTEMIC DISEASE; THRUSH; TISSUE INJURY; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DISEASE MODEL; IMMUNOLOGY; MICROBIOLOGY; MOUTH MUCOSA; PATHOLOGY; STAPHYLOCOCCAL INFECTIONS; TONGUE;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; COINFECTION; DISEASE MODELS, ANIMAL; FEMALE; FLUCONAZOLE; FUNGAL PROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MOUTH MUCOSA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TONGUE;

EID: 84921375039     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02843-14     Document Type: Article

References (59)

1. Brogden KA, Guthmiller JM, Taylor CE. 2005. Human polymicrobial infections. Lancet 365:253-255. http://dx.doi.org/10.1016/S0140-6736(05)17745-9.
2. Jabra-Rizk MA. 2011. Pathogenesis of polymicrobial biofilms. Open Mycol J 5:39-43. http://dx.doi.org/10.2174/1874437001105010039.
3. O'Connell HA, Kottkamp GS, Eppelbaum JL, Stubblefield BA, Gilbert SE, Gilbert ES. 2006. Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm. Appl Environ Microbiol 72:5013-5019. http://dx.doi.org/10.1128/AEM.02474-05.
4. El-Azizi MA, Starks SE, Khardori N. 2004. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol 96:1067-1073.
5. Demuyser L, Jabra-Rizk MA, Van Dijck P. 2014. Microbial cell surface proteins and secreted metabolites involved in multispecies biofilms. Path Dis 70:219-230. http://dx.doi.org/10.1111/2049-632X.12123.
6. Peters B, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. 2012. Polymicrobial interactions in biofilms: impact on pathogenesis and human disease. Clin Microbiol Rev 25:193-213. http://dx.doi.org/10.1128/CMR.00013-11.
7. Brogden KA, Guthmiller JM. 2002. Chapter 21, Polymicrobial diseases: current and future research. In Brogden KA, Guthmiller JM (ed), Polymicrobial diseases. ASM Press, Washington, DC.
8. Jenkinson HF, Douglas JL. 2002. Chapter 18, Interactions between Candida species and bacteria in mixed infections. In Brogden KA, Guthmiller JM (ed), Polymicrobial diseases. ASM Press, Washington, DC.
9. Jenkinson HF, Lala HC, Shepherd MG. 1990. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect Immun 58:1429-1436.
10. Jenkinson HF, Lamont RJ. 2005. Oral microbial communities in sickness and in health. Trends Microbiol 13:589-595. http://dx.doi.org/10.1016/j.tim.2005.09.006.
11. Falsetta ML, Klein MI, Colone PM, Scott-Anne K, Gregoire S, Pai C-H, Gonzalez M, Watson G, Krysan DJ, Bowen WH, Koo H. 2014. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes the virulence of plaque biofilms in vivo. Infect Immun 82:1968-1981. http://dx.doi.org/10.1128/IAI.00087-14.
12. Ganguly S, Mitchell AP. 2011. Mucosal biofilms of Candida albicans. Curr Opin Microbiol 14:380-385. http://dx.doi.org/10.1016/j.mib.2011.06.001.
13. Williams DW, Jordan RPC, Wei XQ, Alves CT, Wise MP, Wilson MJ, Lewis MAO. 2013. Interactions of Candida albicans with host epithelial surfaces. J Oral Microbiol 2013:5. http://dx.doi.org/10.3402/jom.v5i0.22434.
14. Moran G, Coleman D, Sullivan D. 2012. An introduction to the medimedically important Candida species, p 11-25. In Calderone RA (ed), Candida and candidiasis. ASM Press, Washington, DC.
15. Fidel PLJ. 2011. Candida-host interactions in HIV disease implications for oropharyngeal candidiasis. Adv Dent Res 23:45-49. http://dx.doi.org/10.1177/0022034511399284.
16. Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133-163. http://dx.doi.org/10.1128/CMR.00029-06.
17. Perlroth J, Choi B, Spellberg B. 2007. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45:321-346. http://dx.doi.org/10.1080/13693780701218689.
18. de Repentigny L, Lewandowski D, Jolicoeur P. 2004. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 17:729-759. http://dx.doi.org/10.1128/CMR.17.4.729-759.2004.
19. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2:1053-1060. http://dx.doi.org/10.1128/EC.2.5.1053-1060.2003.
20. Chauvel M, Nesseir A, Cabral V, Znaidi S, Goyard S, Bachellier-Bassi S, Firon A, Legrand M, Diogo D, Rossignol T, Naulleau C, d'Enfert C. 2012. A Versatile overexpression strategy in the pathogenic yeast Candida albicans: identification of regulators of morphogenesis and fitness. PLoS One 7:e45912. http://dx.doi.org/10.1371/journal.pone.0045912.
21. Nett JE, Sanchez H, Andes DR. 2011. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell 10:1660-1669. http://dx.doi.org/10.1128/EC.05126-11.
22. Tournu H, Van Dijck P. 2012. Candida biofilms and the host: models and new concepts for eradication. Int J Microbiol 2012:845352. http://dx.doi.org/10.1155/2012/845352.
23. Al-Fattani MA, Douglas LJ. 2006. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55:999-1008. http://dx.doi.org/10.1099/jmm.0.46569-0.
24. Holmes AR, Cannon RD, Jenkinson HF. 1995. Interactions of Candida albicans with bacteria and salivary molecules in oral biofilms. J Ind Microbiol 15:208-213. http://dx.doi.org/10.1007/BF01569827.
25. Holmes AR, McNab R, Jenkinson HF. 1996. Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesinreceptor interactions. Infect Immun 64:4680-4685.
26. Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. 2009. Characterization of mucosal Candida albicans biofilms. PLoS One 4:e7967. http://dx.doi.org/10.1371/journal.pone.0007967.
27. Klotz SA, Gaur NK, De Armond R, Sheppard D, Khardori N, Edwards JE, Lipke PN, El-Azizi M. 2007. Candida albicans Als proteins mediate aggregation with bacteria and yeasts. Med Mycol 45:363-370. http://dx.doi.org/10.1080/13693780701299333.
28. Rehm SJ. 2008. Staphylococcus aureus: the new adventures of a legendary pathogen. Cleveland Clin J Med 75:177-192. http://dx.doi.org/10.3949/ccjm.75.3.177.
29. Otto M. 2013. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med 64:175-188. http://dx.doi.org/10.1146/annurev-med-042711-140023.
30. Thammavongsa V, Missiakas DM, Schneewind O. 2013. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science 342:863-866. http://dx.doi.org/10.1126/science.1242255.
31. Sakoulas G, Moellering RC. 2008. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 46: S360-S367. http://dx.doi.org/10.1086/533592.
32. Kraus D, Peschel A. 2008. Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiol 3:437-451. http://dx.doi.org/10.2217/17460913.3.4.437.
33. Gordon RJ, Lowy FD. 2008. Pathogenesis of Methicillin-Resistant Staphylococcus aureus infection. Clin Infect Dis 46(Suppl 5):S350-S359. http://dx.doi.org/10.1086/533591.
34. Peters B, Ovchinnikova E, Schlecht LM, Hoyer LL, Busscher HJ, van der Mei HC, Krom BP, Jabra-Rizk MA, Shirtliff ME. 2012. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiol 158(Pt 12):2975-2986. http://dx.doi.org/10.1099/mic.0.062109-0.
35. Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME. 2010. Microbial interactions and differential protein expression in Staphylococcus aureus and Candida albicans dual-species biofilms.FEMS Immunol Med Microbiol 59:493-503. http://dx.doi.org/10.1111/j.1574-695X.2010.00710.x.
36. Peters BM, Noverr MC. 2013. Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. Infect Immun 81:2178-2189. http://dx.doi.org/10.1128/IAI.00265-13.
37. Schlecht LS, Peters BM, Krom B, Hänsch GM, Filler SG, Jabra-Rizk MA, Shirtliff ME. 2014. Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology http://dx.doi.org/10.1099/mic.0.083485-0.
38. Timsit JF, Cheval C, Gachot B, Bruneel F, Wolff M, Carlet J, Regnier B. 2001. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med 27:640-647. http://dx.doi.org/10.1007/s001340000840.
39. Pate JC, Jones DB, Wilhelmus KR. 2006. Prevalence and spectrum of bacterial coinfection during fungal keratitis. Br J Ophthalmol 90:289-292. http://dx.doi.org/10.1136/bjo.2005.081869.
40. Tawara Y, Honma K, Naito Y. 1996. Methicillin-resistant Staphylococcus aureus and Candida albicans on denture surfaces. Bull Tokyo Dent Coll 37:119-128.
41. Gupta N, Haque A, Mukhopadhyay G, Narayan RP, Prasad R. 2005. Interactions between bacteria and Candida in the burn wound. Burns 31:375-378. http://dx.doi.org/10.1016/j.burns.2004.11.012.
42. Baena-Monroy T, Moreno-Maldonado V, Franco-Martínez F, Aldape-Barrios B, Quindós G, Sánchez-Vargas LO. 2005. Candida albicans, Staphylococcus aureus, and Streptococcus mutans colonization in patients wearing dental prosthesis. Med Oral Patol Oral Circ Bucal 10:E27-E39.
43. Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine =5=-phosphate decarboxylase by complementation of Saccharomyces cerevisiae ura3 and Escherichia coli pyrF mutations. Mol Gen Genet 198:179-182. http://dx.doi.org/10.1007/BF00328721.
44. Lo H-L, Kohler JR, DiDomenico D, Loebenberg D, Cacciapuoti A, Fink GR. 1997. Nonfilamentous Candida albicans mutants are avirulent. Cell 90:939-949. http://dx.doi.org/10.1016/S0092-8674(00)80358-X.
45. Braun BR, Johnson AD. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105-109. http://dx.doi.org/10.1126/science.277.5322.105.
46. Braun BR, Head WS, Wang MX, Johnson AD. 2000. Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics 156:31-44.
47. Phan QT, Myers CL, Fu F, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE, Filler SG. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cell. PLoS Biol 5:e64. http://dx.doi.org/10.1371/journal.pbio.0050064.
48. Phan QT, Belanger PH, Filler SG. 2000. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68:3485-3490. http://dx.doi.org/10.1128/IAI.68.6.3485-3490.2000.
49. Harro JM, Daugherty S, Bruno VM, Jabra-Rizk MA, Rasko DA, Shirtliff ME. 2013. Draft genome sequence of the methicillin-resistant Staphylococcus aureus isolate MRSA-M2. Genome Announc 1:e00037-12. http://dx.doi.org/10.1128/genomeA.00037-12.
50. Solis NV, Filler SG. 2012. Mouse model of oropharyngeal candidiasis. Nat Protoc 7:637-642. http://dx.doi.org/10.1038/nprot.2012.011.
51. Nasidze I, Quinque D, Li J, Li M, Tang K, Stoneking M. 2009. Comparative analysis of human saliva microbiome diversity by barcoded pyrosequencing and cloning approaches. Anal Biochem 391:64-68. http://dx.doi.org/10.1016/j.ab.2009.04.034.
52. Beaussart A, Herman P, El-Kirat-Chatel S, Lipke PN, Kuchariková S, Van Dijck P, Dufrêne YF. 2013. Single-cell force spectroscopy of the medically important Staphylococcus epidermidis-Candida albicans interaction. Nanoscale 5:10894-10900. http://dx.doi.org/10.1039/c3nr03272h.
53. Xu H, Sobue T, Thompson A, Xie Z, Poon K, Ricker A, Cervantes J, Diaz PI, Dongari-Bagtzoglou A. 2014. Streptococcal coinfection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microbiol 16:214-231. http://dx.doi.org/10.1111/cmi.12216.
54. Martin MV. 1999. The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review. J Antimicrob Chemother 44:429-437. http://dx.doi.org/10.1093/jac/44.4.429.
55. Roux D, Gaudry S, Khoy-Ear L, Aloulou M, Phillips-Houlbracq M, Bex J, Skurnik D, Denamur E, Monteiro RC, Dreyfuss D, Ricard JD. 2013. Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail. Crit Care Med 41:191-199. http://dx.doi.org/10.1097/CCM.0b013e31828a25d6.
56. Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Jr, Noverr MC. 2010. Candida albicans forms biofilms on the vaginal mucosa. Microbiol 156:3635-3644. http://dx.doi.org/10.1099/mic.0.039354-0.
57. Nett JE, Marchillo K, Spiegel CA, Andes DR. 2010. Development and validation of an in vivo Candida albicans biofilm denture model. Infect Immun 78:3650-3659. http://dx.doi.org/10.1128/IAI.00480-10.
58. Salerno C, Pascale M, Contaldo M, Esposito V, Busciolano M, Guida A, Milillo L, Petruzzi M, Serpico R. 2011. Candida-associated denture stomatitis. Med Oral Patol Oral Cir Bucal 16:139-143.
59. Edwards JS, Betts L, Frazier ML, Pollet RM, Kwong SM, Walton WG, Ballentine WK, Huang JJ, Habibi S, Del Campo M, Meier JL, Dervan PB, Firth N, Redinbo MR. 2013. Molecular basis of antibiotic multiresistance transfer in Staphylococcus aureus. Proc Natl Acad Sci U S A 110:2804-2809. http://dx.doi.org/10.1073/pnas.1219701110.